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Histatins are salivary histidine-rich cationic peptides, ranging
from 7 to 38 amino acid residues in length, that exert a potent
killing effect in itro on Candida albicans. Starting from the C-
terminal fungicidal domain of histatin 5 (residues 11–24, called
dh-5) a number of substitution analogues were chemically
synthesized to study the effect of amphipathicity of the peptide in
helix conformation on candidacidal activity. Single substitutions
in dh-5 at several positions did not have any effect on fungicidal
activity. However, multi-site substituted analogues (dhvar1 and
dhvar2) exhibited a 6-fold increased activity over dh-5. In
INTRODUCTION
Candidiasis is an infectious disease caused mainly by Candida
albicans. The development of oral candidiasis is seldom observed
in healthy subjects but seen frequently in people with reduced
saliva output (xerostomia), in people wearing dentures and in
immunocompromised patients [1]. The underlying pathogenesis
of this oral infection is not well understood. The discovery of
histatins, salivary proteins exhibiting fungicidal and fungistatic
properties [2–4], revealed a mechanism by which the colonization
and subsequent oral infection with Candida could be controlled.
Histatins and other antimicrobial peptides with broad-spectrum
activity, including defensins and magainin-like peptides, have
been identified in the oral cavity and could possibly contribute to
the non-immune host defence system [5–7]. The common features
of these host defence peptides are their basic nature, due to
the presence of multiple arginine and lysine residues, and the
proposed mechanism of pore formation in the membrane of the
target organism [8–10]. Histatins are a group of small cationic
histidine-rich proteins secreted by the parotid salivary gland and
to a smaller extent by the submandibular salivary glands [11].
These peptides possess a number of antifungal and antibacterial
properties, such as growth-inhibitory effects on C. albicans
[4,11,12], inhibition of the conversion of C. albicans yeast growth
into hyphal growth [13,14], growth inhibition of Streptococcus
mutans [15] and inhibition of a protease produced by
Porphyromonas gingialis [16].
Three major histatins, histatins 1, 3 and 5, have previously
been purified and characterized [11,17]. CD, IR and NMR
studies on residues 9–24 of histatin 5 indicated that histatins
exhibit random coil conformations in aqueous solution, but that
a-helix conformations are preferred in trifluoroethanol and
DMSO [18,19]. On the basis of these studies a model of pore
formation has been deduced for the mechanism of killing.
Inducibility of amphipathic helical structures would allow the
incorporation of the peptide into the membrane of the target
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addition, dhvar1 and dhvar2 inhibited the growth of the second
most common yeast found in clinical isolates, Torulopsis glabrata,
of oral- and non-oral pathogens such as Preotella intermedia
and Streptococcus mutans, and of a methicillin-resistant Staphy-
lococcus aureus. In their broad-spectrum activity, dhvar1 and
dhvar2 were comparable to magainins (PGLa and magainin 2),
antimicrobial peptides of amphibian origin. Both the fungicidal
and the haemolytic activities of dhvar1, dhvar2 and magainins
increased at decreasing ionic strength.
organism and the formation of a water-filled pore, leading to cell
death [9]. The loss of viability of C. albicans on administration of
histatins has been found to be concomitant with loss of K+ ions
from exposed yeast cells, suggesting that these peptides can
alter membrane permeability and cause membrane damage [4].
Structure–function studies on other pore-forming antimicrobial
peptides revealed that amphipathicity and the a-helical content
are important conditions for antimicrobial activity [8,20–22].
In the present study we chemically synthesized substitution
analogues of histatins with the intention of increasing the lateral
amphipathicity of the helical conformation, and evaluated the
effect on antifungal and antibacterial activity. For comparison,
two antimicrobial peptides of amphibian origin, PGLa (peptide
with N-terminal glycine and C-terminal leucine amide) and
magainin 2, were included. Magainins and histatins do not share
amino acid sequences, but both are expected to form amphipathic
a-helices and to kill their target organism by pore formation [8].
Polylysine of comparable chain length (15-mer) was tested to
evaluate the importance of positive charges on fungicidal activity.
Unlike histatins and magainins, short polylysine peptides do not
adopt helical conformations in liposome vesicles [23] and have
no amphipathic character. The lytic activities of these peptides
against fungal cells and cells from mammalian origin (erythro-
cytes) were compared.
MATERIALS AND METHODS
Strains and growth conditions
C. albicans 315 (ATCC 10231) and Torulopsis glabrata 359
(ATCC 90030) were grown aerobically at 30 °C on Sabouraud
dextrose agar (SDA, Oxoid, Hants., U.K.), Streptococcus mutans
HG 982, S. mutans HG 1003, S. mutans Ingbritt, S. sanguis
(clinical isolate from blood) and Actinobacillus actinomycetem-
comitans Y4 (ATCC 43718) in air}CO
#
(19:1) at 37 °C,
Fusobacterium nucleatum (ATCC 10953), Veillonella parula
(ATCC 17745) and Preotella intermedia (T588) anaerobically at
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37 °C, and Staphylococcus aureus (methicillin resistant, MRSA;
clinical isolate from perineum) on Schaedler F0 agar (Oxoid)
containing 1% (v}v) haemin and 7% (v}v) horse blood
(Biotrading, Mijdrecht, the Netherlands).
C. albicans and T. glabrata were cultured aerobically in tryptic
soy broth (Becton Dickinson, Cockeysville, MD, U.S.A.), F.
nucleatum, V. parula and P. intermedia anaerobically in BM1
medium, and A. actinomycetemcomitans in tryptic soy broth
containing 0.5% yeast extract (Difco, Detroit, MI, U.S.A.) and
0.1% NaHCO
$
, pH¯ 7.2. S. mutans and S. sanguis were cultured
in Todd Hewitt medium (Oxoid) in air}CO
#
(19:1), and Staph.
aureus was cultured aerobically in Brain Heart Infusion (BHI,
Difco).
Induction of germ tube formation
C. albicans was grown in Sd medium [0.17% Yeast Nitrogen
Base without amino acids and (NH
%
)
#
SO
%
(Difco)}0.5%
(NH
%
)
#
SO
%
}0.25% succinic acid (pH 4.5)}2% (w}v) glucose] at
28 °C. To induce germ tube formation, yeast cells in the
exponential growth phase (1!D
&$!
! 2) were collected by
centrifugation and washed once in doubly distilled water. The
yeast cells were then resuspended in a modified Sd medium
containing 0.25% Mes, pH 6.7, and 10 mM N-acetylglucosamine
instead of succinic acid and glucose respectively. These cell
suspensions were shaken for 2 h at 37 °C to develop germ tubes
(hyphae).
Peptides
Histatin derivatives were synthesized by the ‘T-bag’ method,
adapted for fluoren-9-ylmethoxycarbonyl (Fmoc) chemistry, as
described elsewhere [24,25]. T-bags (3.5 cm¬3.5 cm) were made
by sealing 64 lm polypropylene mesh (Chicopee Industries,
Gainesville, GA, U.S.A.). p-Benzyloxybenzyl alcohol resins, with
the first N-Fmoc-protected amino acids already attached, were
included inside the T-bags, in such quantities that each T-bag
contained 50 lmol of the first amino acid.
Coupling reactions were performed for 1 h at ambient tem-
perature in fresh Pro Analyse-grade dimethylformamide, from
which the degradation product dimethylamine was removed by
sparging with nitrogen. A 10-fold excess of N-Fmoc-protected
amino acid was used with respect to the loading of the first amino
acid on the resin. As coupling reagent a 10-fold excess of 2-(1H-
benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate
(TBTU) was used; to prevent racemization a 10-fold excess of 1-
hydroxybenzotriazole (Fluka, Buchs, Switzerland) was added;
and for activation a 13-fold excess of N,N-di-isopropylethylamine
(Aldrich, Bornem, Belgium) was used. After each coupling step
the T-bags were extensively washed with dimethylformamide,
dichloromethane and propan-2-ol. TBTU, the preloaded resins
and the amino acid derivatives were purchased from Nova-
biochem}Calbiochem (La$ ufelfingen, Switzerland).
Semi-permanent side chain protection of arginine was achieved
with the NG-2,2,5,7,8-pentamethylchroman-6-sulphonyl group,
of histidine and cysteine with the triphenylmethyl group, and of
tryptophan with the t-butoxycarbonyl group. Asparagine and
glutamine were used without side chain protection. For the other
amino acids the standard t-butoxycarbonyl}t-butyl side chain
protection strategy was followed.
After completion of the sequence, cleavage from the resin and
simultaneous side chain deprotection were achieved with a
mixture of 5% (v}v) thioanisole, 5% (w}v) phenol, 5% (v}v)
water and 85% (v}v) trifluoroacetic acid (5 ml per T-bag) at
ambient temperature within 4 h. The volume was reduced to 1 ml
by evaporation of most of the trifluoroacetic acid with a stream
of nitrogen. On addition to ice-cold ether (15 ml) the peptides
precipitated. The T-bags were extracted twice with acetic acid
(3 ml per T-bag) and these extracts were added to the ether
phase. After the ether had been decanted, the combined precipi-
tates were triturated with ether and dissolved in water. After
extraction with ether to remove the last traces of scavengers the
peptides were freeze-dried.
For purity analysis reverse-phase HPLC was performed with
an Applied Biosystems C
")
column (ODS, 220 mm¬4.6 mm) in
conjunction with a Spectroflow 480 HPLC system and two
Spectroflow 400 pumps (ABI Kratos Analytical Division).
Samples were monitored at 214 nm with a 783 programmable
absorbance detector (ABI Applied Biosystems). Buffer A con-
sisted of 0.1% (v}v) trifluoroacetic acid in water and buffer B
of 0.1% (v}v) trifluoroacetic acid in acetonitrile. The gradient
was run from 0 to 100% buffer B at a flow rate of 1 ml}min.
Synthetic PGLa (95% pure) was kindly provided by Professor
H. V. Westerhoff (Department of Microbial Physiology, Vrije
Universteit, Amsterdam, The Netherlands). Synthetic magainin
2 was a gift from Dr. B. J. Appelmelk (Department of Medical
Microbiology, Vrije Universiteit, Amsterdam, The Netherlands).
Poly-l-lysine (degree of polymerization, 15 residues ; approxi-
mate molecular mass based on viscosity determination, 3000 Da)
was obtained from Sigma (St. Louis, MO, U.S.A.).
All peptides were water-soluble and dissolved in 10 mM
potassium phosphate buffer (PPB), pH 7.0, to a final con-
centration of 2 mg}ml. The exact concentrations were determined
by amino acid analysis. Stock solutions were stored at ®80 °C in
Eppendorf vials.
Killing assay
The fungicidal assay was performed largely by the method of Raj
et al. [18]. In 96-well culture plates (Greiner), peptides were
diluted 2-fold serially in 1 mM PPB, pH 7.0, starting from
250 lg}ml. Columns 1 and 2 served as growth controls (no
peptide added). Before the experiment, C. albicans 315 was
cultured from glycerol on SDA and maintained for at most 1
week. Several yeast colonies were picked up from the plate and
suspended in 1 mM PPB, pH 7.0, to yield a suspension of 10(
colony-forming units}ml (1 McFarland suspension). Of this
suspension 50 ll was added to each well to yield a final volume
of 100 ll per well. After 1.5 h of incubation with shaking
(900 rev.}min) at 37 °C, 50 ll from selected wells was diluted
200-fold in PBS [9 mM sodium phosphate (pH 7.0)}150 mM
NaCl], in which the peptides were inactive, and surviving cells
were determined by plating 25 ll on SDA. After 48 h of
incubation at 30 °C, the percentage viability was calculated by:
(number of viable cells}mean number of viable cells in growth
control)¬100%. The killing assay was also performed in 10, 20,
50 and 100 mM PPB.
Growth inhibition on agar
In addition to the killing assay, growth inhibition on agar was
studied by the method of Westerhoff et al. [26]. Yeast and
bacterial cells cultured for 16 h were harvested by centrifugation
and diluted in PBS to a concentration to grow just confluently
when plated with a cotton swab on SDA plates (yeast strains) or
Schaedler F0 plates (bacterial strains). Plates were then dried for
15 min at room temperature ; 5 ll (10 lg) samples of peptide
were spotted on the surface of the plate. After 16 h of incubation,
the plates were screened for spots of growth inhibition.
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Haemolytic assay
A haemolytic assay was performed in a high-ionic-strength
buffer (PBS) and in a low-ionic-strength buffer [isotonic glucose
(287 mM)}1 mM PPB}2.5% PBS]. Human erythrocytes (blood
group O­) were maintained in PBS and kept at 4 °C for up to
3 weeks. The erythrocytes were harvested by centrifugation and
washed three times in PBS. In 96-well V-bottomed microtitre
plates, peptides were diluted 2-fold serially in high-ionic-strength
or low-ionic-strength buffer, starting at 167 lg}ml. Human
erythrocytes were diluted in high-ionic-strength or low-ionic-
strength buffer to yield a 1% suspension. Of this suspension
75 ll was added to each well (final concentration 0.5% in 150 ll
total volume). After 1 h of incubation at 37 °C, the plates were
centrifuged at 3000 rev.}min for 5 min. The supernatant fluid
was separated from the pellet and the absorbance measured at
540 nm. Non-haemolytic controls and 100% haemolysis were
determined in buffer alone and in buffer containing 1% (w}v)
Triton X-100 (Merck), respectively.
RESULTS
Peptide design
For the design of histatin derivatives with improved antifungal
activity we synthesized substitution analogues of residues 11–24
of histatin 5 (designated dh-5), which has been reported to
comprise the fungicidal domain [18]. In dh-5, projected as a
regular a-helical structure of 3.6 residues per turn, both a
hydrophilic and a hydrophobic face have been distinguished [19]
(Figure 1). The hydrophobic face is made up of Ser#!, Lys"$,
Tyr#%, Lys"(, His#" and Phe"%, the hydrophilic face of Glu"',
Gly#$, Arg"#, His"*, His"&, Arg## and Lys"", with His") at the
interface, resulting in a weakly amphipathic a-helix. Histidine
and lysine residues at the putative hydrophobic face and possibly
deprotonated histidine residues at the hydrophilic face decrease
the amphipathic character of this helix. These amino acids were
Figure 1 Helical-wheel presentation of residues 11–24 of histatin 5
(dh-5)
Substitution analogues of dh-5 are based on this diagram. The substituted residues are
indicated by arrows.
Table 1 Amino acid sequences and anti-Candida activity of histatin
analogues
Notation : ­, complete inhibition ; ®, no inhibition ; a, amide.
Growth
Peptide Sequence Killing IC50 (lM) inhibition on agar
h-5 DSHAKRHHGYKRKFHEKHHSHRGY 1.4 ®
dh-5 KRKFHEKHHSHRGY 4.1 ®
dh13L KKRLFHEKHHSHRGY 5.2 ®
dh15K KRKFKEKHHSHRGY 2.1 ®
dh17L KRKFHELHHSHRGY 3.0 ®
dh18L KRKFHEKLHSHRGY 3.0 ®
dh18K KRKFHEKKHSHRGY 2.6 ®
dh19K KRKFHEKHKSHRGY 2.5 ®
dh21F KRKFHEKHHSFRGY 2.9 ®
dh23K KRKFHEKHHSHRKY 2.9 ®
dhvar1 KRLFKELKFSLRKY 0.6 ­
dhvar2 KRLFKELLFSLRKY 0.8 ­
PGLa GMASKAGAIAGKIAKVALKALa 0.6 ­
Magainin 2 GIGKFLHSAKKFGKAFVGEIMNSa 1.0 ­
Polylysine KKKKKKKKKKKKKKK 0.6 ®
dCysSN SSPGKPPRLVGGP " 114 ®
Figure 2 Hydrophobic moment profile of histatin analogues
The hydrophobic moments (l) were plotted as a function of the angle between the amino acid
side chains for dh-5 (U), dhvar1 (D) and dhvar2 (_).
substituted by residues that contribute to amphipathicity. Two
groups of dh-5 analogues were synthesized (Table 1). The first
group consisted of peptides with substitutions at a single site, and
the second group had substitutions at several sites. To eliminate
the possible effect of (de)protonation, the histidine residue in the
hydrophobic face was replaced by phenylalanine (analogue
dh21F) and histidine residues in the hydrophilic face were
replaced by lysines (dh15K, dh19K). His") at the transition area
was replaced by either lysine or leucine (dh18K and dh18L
respectively). Lysine residues in the hydrophobic face were
replaced by leucines (dh17L, dh13L), and the glycine residue in
the hydrophilic face was replaced by lysine (dh23K). Histatin 5
and dh-5 were synthesized and used as reference material.
Purity analysis by reverse-phase HPLC and subsequent
purification of the peptides demonstrated the screen-grade purity
of one major peak with only slight contamination (less than
5%). The determined amino acid composition corresponded to
the calculated values.
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Figure 3 C. albicans hyphae without (upper panel) and with (lower panel)
histatin 5
Photographs were taken after 1.5 h of incubation at 37 °C in 1 mM PPB without and with
histatin 5 (12 lM).
In Figure 2 the hydrophobic moments (l) of dh-5, dhvar1
and dhvar2 are given as a function of the angle (d) between the
amino acid side chains by using the equation:
l¯ 3
N
n="
H
n
eidn (1)
where H
n
is the numerical hydrophobicity of the nth residue, and
N is the total number of amino acid residues [27]. The hydro-
phobic moment measures the amphipathicity of the N residues of
a protein segment.
Analogue dh-5 displayed a maximum at 108° (l¯ 2.9), which
indicates optimal amphipathicity in a 3
"!
-helix conformation
rather than in a pure a-helix conformation, where d¯ 100°. The
slight preference of dh-5 for a 3
"!
-helix conformation has been
confirmed by CD measurements [18]. Analogues dhvar1 and
dhvar2 displayed a maximum at 100°, suggesting the preference
of these peptides for an a-helical conformation. Furthermore the
maximum hydrophobic moment of dhvar1 and dhvar2 (l¯ 6.1)
was about twice the maximum hydrophobic moment of dh-5.
Candidacidal activity of histatin analogues
The micrographs shown in Figure 3 show the effect of histatin 5
(12 lM) on C. albicans germ tubes. After 1.5 h of incubation at
Figure 4 Anti-Candida activity of histatin analogues
The percentage viability was determined by plating after 1.5 h of incubation at 37 °C in 1 mM
PPB with histatin 5 (*), dh-5 (U), dh19K (¬), dhvar1 (D), PGLa (o), polylysine (y)
and dCysSN (­, negative control).
37 °C, a decrease in number and size of the cells as well as
fragmentation of the cell structure was observed, caused either
by direct activity on the cell wall or by autolysis as a secondary
effect of de-energization of the cells. No colonies were formed
when the histatin-treated hyphae were plated on SDA agar. We
found that the susceptibility of C. albicans germ tubes was of the
same order of magnitude as the susceptibility of C. albicans
blastoconidia to histatin 5 (results not shown).
In Figure 4 the killing curves are shown for dh-5, dh19K
(containing a single substitution) and dhvar 1 (containing several
substitutions). PGLa, a helix-forming broad-spectrum anti-
microbial peptide of amphibian origin, was used for comparison,
and 15-mer polylysine was tested as a positively charged control.
As a negative control a synthetic peptide was included that
encompassed residues 1–14 of cystatin SN (dCysSN), which
displays neither helix formation nor amphipathicity.
From these killing curves the IC
&!
values (concentrations at
which half the Candida inoculum was killed) were determined
(Table 1). All killing experiments were performed in triplicate on
different occasions, and the mean IC
&!
values are shown. The
variation in IC
&!
values between experiments was 30% at most.
The activity of dh-5 was found to be one-third that of the
complete synthetic histatin 5 molecule (IC
&!
values 4.1 and
1.4 lM respectively). The IC
&!
values of dh-5 analogues with
single-site substitutions ranged from 2.1 to 5.2 lM, indicating
that substitutions at single sites had little effect on the fungicidal
potency of dh-5. Analogues with multi-site substitutions were
more fungicidal than the reference peptides : the IC
&!
values of
dhvar1 and dhvar2 were 0.6 and 0.8 lM respectively, a 6-fold
increase over dh-5 and a 2-fold increase over histatin 5. The
activity of dhvar1 and dhvar2 was comparable to the activity of
PGLa and magainin 2. Remarkably, under these test conditions
polylysine was fungicidal to the same extent as dhvar1 and PGLa
(IC
&!
1 lM).
The presence of ions can affect the activity of several anti-
microbial peptides, including histatins [14]. The activities of
histatin 5, dhvar1, dhvar2, PGLa and magainin 2 were therefore
investigated at increasing PPB concentrations (1, 10, 20, 50 and
100 mM). Figure 5 shows that the activities of all peptides
decreased at increasing PPB concentration. Histatin 5 was most
sensitive : in buffer concentrations above 20 mM PPB, little or no
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Figure 5 Influence of the ionic strength on candidacidal activity
The IC50 values of histatin 5 (*), dhvar1 (D), dhvar2 (_), PGLa (o) and magainin 2 (+)
are shown at increasing PPB concentration. The highest peptide concentration tested was
32 lM.
Table 2 Growth inhibition on agar
Notation : ­, complete inhibition ; ­/®, partial inhibition ; ®, no inhibition.
Growth inhibition
Micro-organism Histatin 5 dhvar1 dhvar2 PGLa Magainin 2 Polylysine
C. albicans ® ­ ­ ­ ­ ®
T. glabrata ® ­ ­ ­ ­ ®
S. mutans HG 982 ® ­ ­ ­ ­ ®
S. mutans HG 1002 ® ­ ­ ­ ­ ®
S. mutans Ingbritt ® ­ ­ ­ ­ ®
S. sanguis ® ­ ­ ­ ­ ®
A. actinomycetemcomitans ® ® ® ­/® ­ ®
F. nucleatum ® ­ ­ ­ ­ ®
V. parvula ® ­ ­ ­ ­ ®
P. intermedia ® ­ ­ ­ ­ ®
Staph. aureus (MRSA) ® ­/® ­/® ­ ­ ®
fungicidal activity was observed. In contrast, dhvar1, dhvar2,
PGLa and magainin 2 were still active at 20 mM PPB, but IC
&!
values increased at buffer concentrations above 50 mM PPB. In
100 mM PPB, less than 50% killing was found at the highest
peptide concentrations tested (32 lM). The same effect was
observed at increasing concentrations of NaCl (results not
shown).
Growth inhibition on agar
Growth inhibition on agar (visible as a circular clear spot after
16 h of incubation) was scored as positive when observed at least
twice in three independent experiments (Table 1). Histatin 5,
dh-5, singly substituted dh-5 analogues and polylysine did
not inhibit the growth of C. albicans in this assay. In contrast
with these peptides, dhvar1, dhvar2, PGLa and magainin 2
caused clear spots of growth inhibition.
To investigate whether dhvar1 and dhvar2 exhibited broad-
spectrum activity, the susceptibility of a number of oral and non-
Table 3 Fungicidal and haemolytic activities
Abbreviations : LI, low-ionic-strength ; HI, high-ionic-strength.
Concentration for
IC50 (lM) 50% haemolysis (lM)
Peptide In LI buffer In HI buffer In LI buffer In HI buffer
Histatin 5 2.9 " 23 " 32 " 32
dhvar1 0.9 " 48 5.3 " 65
dhvar2 0.9 " 42 7.1 " 57
PGLa 4.9 " 39 10.3 " 52
Magainin 2 2.3 " 29 2.9 " 39
Polylysine 1.3 " 25 " 33 " 33
oral pathogenic micro-organisms was tested in the same way
(Table 2). T. glabrata, comprising 10% of the clinical isolates
[28], three strains of S. mutans, associated with caries, S. sanguis,
an oral commensal, and F. nucleatum, V. parula and P.
intermedia, associated with periodontitis, were inhibited by
dhvar1 and dhvar2. The growth of a methicillin-resistant Staph.
aureus strain (MRSA) was partly inhibited; some surviving cells
grew in the clear spot (indicated by ­}®). The growth of A.
actinomycetemcomitans, a species that is related to juvenile
periodontitis, was not inhibited by dhvar1 and dhvar2. Magainin
2 inhibited all micro-organisms tested, including A. actino-
mycetemcomitans. In this assay, neither histatin 5 nor polylysine
inhibited any of these oral micro-organisms. When histatin 5 was
spotted at a concentration 10 times higher (100 lg), the growth
of C. albicans and S. sanguis was slightly inhibited (results not
shown).
Fungicidal and haemolytic activities
For a proper comparison of the fungicidal and haemolytic
activities, both assays were conducted in the same buffers.
Because it was found that the fungicidal activity was strongly
dependent on the ionic strength, the fungicidal and haemolytic
activities of a number of peptides were determined at high- and
low-ionic-strength isotonic conditions (Table 3). The haemolytic
assay was performed three times on independent occasions. The
variation between experiments was 35% at most. The fungicidal
activity was determined by the standard viability assay. In low-
ionic-strength buffer all peptides displayed fungicidal activities,
with IC
&!
values ranging from 0.9 to 4.9 lM. Those peptides
exhibiting broad-spectrum antimicrobial activity (dhvar1,
dhvar2, PGLa and magainin 2) also showed haemolytic activity
(50% haemolysis at 5.3, 7.1, 10.3 and 2.9 lM respectively). In
contrast, histatin 5 and polylysine were not haemolytic under
these conditions at concentrations up to 32 lM. Under high-
ionic-strength conditions (PBS), the peptides were not active,
either against fungal cells or against erythrocytes.
DISCUSSION
In the present study we investigated the effect of substitutions in
a histatin derivative, dh-5, on antimicrobial and haemolytic
activities, thereby focusing on helix amphipathicity. One of the
key determining features of a peptide to act as a membrane-
active antimicrobial peptide is the ability to adopt helical
conformations with lateral amphipathicity [8,29]. These proper-
ties are linked because sequences that form a-helices tend to have
a strong periodicity in the hydrophobicity of 3.6 residues, the
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period of the a-helix ; in contrast, amphiphilicity is a factor in the
folding of proteins [20,22,27]. Because of their basic nature and
weakly amphipathic character, histatins are considered to be
members of the family ofmembrane-active antimicrobial peptides
[8,19]. A reasonable approach to improving the antimicrobial
activity of dh-5 was to replace those amino acid residues that do
not contribute to the spatial segregation of hydrophobic and
hydrophilic amino acids (hydrophobic moment) in an optimal a-
helix model. In this model, substitutions at single loci in dh-5 do
not significantly improve the a-helix amphipathicity (hydro-
phobic moment of dh-5, 2.07; mean hydrophobic moment of the
single-site substitution analogues, 2.67) and we found no signifi-
cant effect on the antifungal activity. However, the amphi-
pathicity of dhvar1 and dhvar2 (mean hydrophobic moment,
6.03) was increased 3-fold when compared with dh-5 in an a-
helix conformation, or 2-fold when compared with dh-5 in a
3
"!
-helix conformation. In accordance with these data, a sig-
nificant increase in antifungal activity was observed. Moreover,
broad-spectrum activity emerged as a result of these substitutions
and in terms of their antifungal and haemolytic activities a
comparison between dhvars and magainins seems to be allowed.
We found that substitution of amino acid residues at positions
13, 15, 17, 18, 19, 21 and 23 of dh-5 hardly influenced antifungal
activity. It is worth noticing that in dhvar1 and dhvar2 all
histidine residues had been replaced. Therefore the high histidine
content in both the antifungal protein from Sarcophaga peregrina
and histatins does not seem to be an explanation for their shared
antifungal activity [30]. Our findings are consistent with the
reports on magainins and cecropins that amphipathic structures
rather than strict primary sequences are important for membrane
permeation, and that specific peptide}receptor interactions are
not likely to be involved [8].
Besides the ability to form amphipathic structures, a net
positive charge is essential for activity [8]. In our killing assay,
polylysine was as active as a fungicide as PGLa, dhvar1 and
dhvar2. The mechanism of antibacterial activity of short poly-
lysine peptides (10–30-mer) is generally ascribed to electrostatic
adsorption to the cell surface, followed by stripping of the outer
membrane and abnormal distribution of the cytoplasm [31].
Comparable effects were observed for Candida on incubation
with histatin 5. Because all basic peptides tested exhibited
antifungal activity in low-ionic-strength buffer, it cannot be
excluded that, under these conditions, the mechanism of fungi-
cidal activity of histatins is comparable to that of polylysine,
namely membrane disintegration as a result of peptide adsorption
to negatively charged groups on the membrane. This is further
confirmedby the finding that under less favourable test conditions
(e.g. at higher ionic strength) polylysine and histatin 5 show a
strong decrease in fungicidal potency, suggesting that their
activity relies mainly on weak electrostatic interactions. The
stronger activity of the analogues dhvar1 and dhvar2 compared
with histatin 5 and polylysine was demonstrated at conditions of
higher ionic strength and by the spot-assay on agar.
The involvement of electrostatic interactions has been demon-
strated for a broad range of basic antimicrobial peptides,
including histatins, by a decrease in activity at increasing ionic
strength [5,14,30,32–35]. This phenomenon is generally explained
by the shielding of charged groups on the peptide and the
membrane, thereby preventing interaction between them [36].
We found an ionic strength dependence for all histatin analogues.
However, dhvar1 and dhvar2, unlike histatin 5, were still highly
active at 20 mM PPB, for which the ionic strength is comparable
to that of saliva. The difference in the activities of histatin 5 on
the one hand and the broad-spectrum peptides on the other hand
might reflect the difference in the strength of the binding and
hence in the affinity as determined by hydrophilic and hydro-
phobic interactions and by the proper peptide conformation.
It is thought that antimicrobial peptides are preferentially
selective for prokaryotic membranes, but the basis for specificity
at a molecular level is not yet known. Liposomes composed of
anionic phospholipids are efficiently lysed by cecropins [37] and
by magainins [38]. The absence of acidic phospholipids from the
outer leaflet of erythrocytes and the abundant presence of
cholesterol combined with a weak transmembrane potential
contribute to the protection of erythrocytes against attack by
magainins. The generation of an inside negative potential
enhances magainin-induced haemolysis [36,38]. These reports
indicate that electrostatic interactions are necessary for effective
lysis. Testing the haemolytic activity of antimicrobial peptides is
usually performed in PBS [22,39,40,41]. We found no haemolytic
activity on testing in PBS, but also no antifungal activity of
histatin derivatives and magainins. At lower ionic strength, the
most active peptides (dhvars and magainins) caused haemolysis,
so that the apparent specificity of this kind of peptides for the
microbial membrane is nullified at low ionic strength. Thus the
present study suggests that enhanced antimicrobial activity is
concomitant with increased haemolytic activity. Improvement of
the antimicrobial activity of magainin 2 increased its ability to
lyse erythrocytes [21]. However, other studies on model amphi-
pathic peptides report that enhancement of antimicrobial activity
is not necessarily coupled with an increase in haemolytic activity
[20,42]. In contrast with the latter studies, we performed the
fungicidal and the haemolytic assay in the same buffers, which
makes the results fully comparable.
This study demonstrates that the a-helix model of dh-5 is a
good starting point for developing histatin analogues with
improved antimicrobial activity. It seems that modifications
that enhance amphipathicity are attended with the appearance
of broad-spectrum activity and hence the loss in specificity.
Although this model seems applicable, the mechanism by which
the analogues kill their target organism might be different from
that of dh-5 or natural histatin 5.
Because of the increasing number of microbial strains with
intrinsic resistance or decreased susceptibility emerging during
prophylaxis or therapy, there is a pressing need for the de-
velopment of new antimicrobial agents with broad-spectrum
antimicrobial activity [43]. Broad-spectrum antimicrobial
peptides interacting with essential cell wall components, such as
lipopolysaccharides or acidic phospholipids, are expected to be
less vulnerable to resistance and might find an application in the
treatment of infections caused by persistent micro-organisms.
For example, the efficacy of a magainin analogue is currently
being evaluated in clinical trials for the treatment of impetigo
and diabetic ulcers [8]. Until now, no induction of resistance
against these kind of peptide has been described. Histatins are
mammalian oral anticandidal peptides, and analogues with
improved activity might provide a good alternative or supplement
to prevent the recurrence of oral candidiasis.
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